Search research articles
Contact Us
Filters
Showing results (91-100 of 124) with videos related to
Page
of 13
Sort By:
Pharmacogenetics and Genomics
|
September 30, 2008
Molecular investigation of the functional relevance of missense variants of ICAM-1
Peter Vischer, Ralph Telgmann, Boris Schmitz, et al.
Journal of the American Society of Nephrology : JASN
|
November 3, 2018
Dose-Dependent Effect of Enzyme Replacement Therapy on Neutralizing Antidrug Antibody Titers and Clinical Outcome in Patients with Fabry Disease
Malte Lenders, Leon Paul Neußer, Michael Rudnicki, et al.
Orphanet Journal of Rare Diseases
|
May 5, 2016
Alpha-Galactosidase A p.A143T, a non-Fabry disease-causing variant
Malte Lenders, Frank Weidemann, Christine Kurschat, et al.
Basic Research in Cardiology
|
April 21, 2015
Soluble Flt-1 links microvascular disease with heart failure in CKD
Giovana S Di Marco, Dominik Kentrup, Stefan Reuter, et al.
Journal of Lipid Research
|
February 18, 2005
Alcohol intake modulates the genetic association between HDL cholesterol and the PPARgamma2 Pro12Ala polymorphism
Stefan-Martin Brand-Herrmann, Tatiana Kuznetsova, Andreas Wiechert, et al.
Journal of Hypertension
|
December 5, 2006
-391 C to G substitution in the regulator of G-protein signalling-2 promoter increases susceptibility to the metabolic syndrome in white European men: consistency between molecular and epidemiological studies
Kathleen Freson, Katarzyna Stolarz, Raymond Aerts, et al.
Hypertension (Dallas, Tex. : 1979)
|
April 17, 2008
Blood pressure and renal sodium handling in relation to genetic variation in the DRD1 promoter and GRK4
Jan A Staessen, Tatiana Kuznetsova, Haifeng Zhang, et al.
Journal of Hypertension
|
April 13, 2004
Relationship between left ventricular mass and the ACE D/I polymorphism varies according to sodium intake
Tatiana Kuznetsova, Jan A Staessen, Katarzyna Stolarz, et al.
Journal of the American Society of Nephrology : JASN
|
July 18, 2015
Patients with Fabry Disease after Enzyme Replacement Therapy Dose Reduction and Switch-2-Year Follow-Up
Malte Lenders, Sima Canaan-Kühl, Johannes Krämer, et al.
Atherosclerosis
|
October 1, 2013
Increased monocyte adhesion by endothelial expression of VCAM-1 missense variation in vitro
Boris Schmitz, Peter Vischer, Eva Brand, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 124) with videos related to
Sort By:
Page
of 13
Pharmacogenetics and Genomics
|
September 30, 2008
Molecular investigation of the functional relevance of missense variants of ICAM-1
Peter Vischer, Ralph Telgmann, Boris Schmitz, et al.
Journal of the American Society of Nephrology : JASN
|
November 3, 2018
Dose-Dependent Effect of Enzyme Replacement Therapy on Neutralizing Antidrug Antibody Titers and Clinical Outcome in Patients with Fabry Disease
Malte Lenders, Leon Paul Neußer, Michael Rudnicki, et al.
Orphanet Journal of Rare Diseases
|
May 5, 2016
Alpha-Galactosidase A p.A143T, a non-Fabry disease-causing variant
Malte Lenders, Frank Weidemann, Christine Kurschat, et al.
Basic Research in Cardiology
|
April 21, 2015
Soluble Flt-1 links microvascular disease with heart failure in CKD
Giovana S Di Marco, Dominik Kentrup, Stefan Reuter, et al.
Journal of Lipid Research
|
February 18, 2005
Alcohol intake modulates the genetic association between HDL cholesterol and the PPARgamma2 Pro12Ala polymorphism
Stefan-Martin Brand-Herrmann, Tatiana Kuznetsova, Andreas Wiechert, et al.
Journal of Hypertension
|
December 5, 2006
-391 C to G substitution in the regulator of G-protein signalling-2 promoter increases susceptibility to the metabolic syndrome in white European men: consistency between molecular and epidemiological studies
Kathleen Freson, Katarzyna Stolarz, Raymond Aerts, et al.
Hypertension (Dallas, Tex. : 1979)
|
April 17, 2008
Blood pressure and renal sodium handling in relation to genetic variation in the DRD1 promoter and GRK4
Jan A Staessen, Tatiana Kuznetsova, Haifeng Zhang, et al.
Journal of Hypertension
|
April 13, 2004
Relationship between left ventricular mass and the ACE D/I polymorphism varies according to sodium intake
Tatiana Kuznetsova, Jan A Staessen, Katarzyna Stolarz, et al.
Journal of the American Society of Nephrology : JASN
|
July 18, 2015
Patients with Fabry Disease after Enzyme Replacement Therapy Dose Reduction and Switch-2-Year Follow-Up
Malte Lenders, Sima Canaan-Kühl, Johannes Krämer, et al.
Atherosclerosis
|
October 1, 2013
Increased monocyte adhesion by endothelial expression of VCAM-1 missense variation in vitro
Boris Schmitz, Peter Vischer, Eva Brand, et al.
Page
of 13